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A 74-year-old man was referred to our hospital because ofa gait disturbance. Positron emission tomography and
computed tomography scans revealed a tumor in his left
lower lobe, but no other lesions were found. Multiple brain
tumors compatible with metastatic tumors were found with
magnetic resonance imaging of the brain (Figure 1A). A
histologic examination via transbronchial biopsy revealed
adenocarcinoma, and the patient was diagnosed with meta-
static non-small cell lung cancer. Epidermal growth factor
receptor gene mutational analysis revealed that the cancer
was of the wild type. After whole-brain radiotherapy, six
cycles of chemotherapy consisting of cisplatin and gemcitab-
ine were administered. The primary lung tumor remained as
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FIGURE 1. A, Brain magnetic resonance image taken on admission shows bilateral masses in the brain. B, Brain magnetic res-
onance image taken on deterioration of symptoms shows bilateral crescent-shaped isointensity lesions (arrowheads) and a
shrunken brain mass (arrow).
FIGURE 2. Adenocarcinoma cells detected in hematoma
fluid.
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a stable disease. However, metastatic brain tumors responded
to whole-brain radiotherapy and sequential chemotherapy.
Two months after six cycles of chemotherapy, he complained
of deterioration in his gait disturbance. Brain magnetic reso-
nance imaging showed bilateral subdural hematoma with a
cerebral tumor (Figure 1B). We considered a possible trau-
matic onset and therefore asked a neurosurgeon to drain the
hematoma. After neurosurgeons drained only the right side,
fluid cytology revealed adenocarcinoma cells (Figure 2). We
concluded that the subdural hematoma was associated with
central nervous system (CNS) metastases (brain and lepto-
meningeal metastases) from lung cancer. His symptoms did
not improve despite the drainage. Although erlotinib and
pemetrexed were administered successively, both were inef-
fective. As his performance status gradually worsened, best
supportive care was chosen. He has since survived 2 months
after best supportive care was chosen.
Bilateral subdural hematoma associated with neoplastic
invasion to CNS is a rare complication, particularly in cases
of lung cancer.1–3 We assume that disseminated cancer cells
from brain tumors invaded the dura and promoted vascular
permeability, resulting in leptomeningeal metastases and the
formation of hematoma. We should be aware of the possibil-
ity of nontraumatic subdural hematoma caused by CNS
metastases from lung cancer.
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